Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02008526 |
|
Recruitment Status :
Completed
First Posted : December 11, 2013
Results First Posted : September 18, 2017
Last Update Posted : September 18, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Methamphetamine Abuse HIV | Behavioral: Text Messages Transmitted by Peer Health Educators (TXT-PHE) Behavioral: Text Messages Transmitted by Automation (TXT-Auto) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 286 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM |
| Study Start Date : | January 2014 |
| Actual Primary Completion Date : | January 2017 |
| Actual Study Completion Date : | January 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: TXT-PHE
Gay-specific, Theory-based Text Messages Transmitted by Peer Health Educators (TXT-PHE) This condition is interactive and tailored to the needs of the individual participant. PHEs initiate (i.e., "push") text messages to participants and also respond to participant-initiated queries and participant responses to the PHE messages (i.e., "pull"). Participants receive five pre-written messages per day sent on a predetermined schedule. Participants who respond to the pre-written text messages or initiate queries or requests for support ("pull") are sent additional real-time messages back from the PHE. During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days. |
Behavioral: Text Messages Transmitted by Peer Health Educators (TXT-PHE)
Participants receive five gay-specific, theory-based pre-written messages per day sent on a predetermined schedule. Participants who respond to the pre-written text messages or initiate queries or requests for support ("pull") are sent additional real-time messages back from the PHE. Text messages are transmitted and responded to in real time, at the peak hours of high-risk activities. During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days. |
|
Experimental: TXT-Auto
Group 2: Gay-specific, Theory-based Text Messages Transmitted by Automation (TXT-Auto) Participants assigned to this group receive automatic text-messages. Following the initial welcome message, participants receive five pre-written messages per day sent on a predetermined schedule. During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days. |
Behavioral: Text Messages Transmitted by Automation (TXT-Auto)
Participants receive five gay-specific, theory-based pre-written messages per day sent on a predetermined schedule. During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days. |
|
No Intervention: Assessment Only (AO)
During the 8-week intervention, participants receive a brief weekly text-based assessment on their methamphetamine use and HIV sexual behaviors in the previous seven days.
|
- Methamphetamine Use [ Time Frame: 9-months post randomization ]Self-reported and/or biomarker-confirmed methamphetamine use assessed at baseline and 9-month follow-up assessment.
- HIV Sexual Risk Behavior [ Time Frame: 9-months post randomization ]Engagement in condomless anal intercourse was assessed at baseline and 9-month post-randomization follow-up.
- Cost Effectiveness [ Time Frame: up to 36 months ]Cost-effectiveness data is collected quarterly throughout the course of the study using the UNAIDS template.
- HIV Primary Care [ Time Frame: 8-weeks post randomization, 3-/6-/9-months post randomization ]HIV-positive participants will be assessed according to their linkage/retention in HIV primary care and adherence to ART medication at 8-weeks, 3-, 6-, and 9-months post-randomization.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Self-identified MSM
- Between the ages of 18 and 65 years
- Methamphetamine use within the previous 3 months
- Unprotected anal intercourse (insertive or receptive) with a non-primary male partner in the previous 6 months
- Not currently in treatment or seeking methamphetamine abuse treatment
- Able and willing to fully charge a cellular phone daily
- Able and willing to provide informed consent
- Able and willing to comply with study requirements
Exclusion Criteria:
- Does not identify as a MSM
- Not between the ages of 18 and 65 years
- Has not used methamphetamine in the previous 3 months
- Has not had unprotected anal intercourse (insertive or receptive) with a non-primary male partner in the previous 6 months
- Currently in treatment or seeking methamphetamine abuse treatment
- Unable or unwilling to fully charge a cellular phone daily
- Unable or unwilling to provide informed consent
- Unable or unwilling to comply with study requirements
- Unable to understand the Informed Consent Form
- Determined to have a more serious psychiatric condition (SCID verified) that is beyond the safe enrollment of study procedures
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02008526
| United States, California | |
| Friends Community Center, a division of Friends Research Institute, Inc., Los Angeles, CA 90028 | |
| Los Angeles, California, United States, 90028 | |
| Principal Investigator: | Cathy J Reback, Ph.D. | Friends Research Institute, Inc. |
| Responsible Party: | Friends Research Institute, Inc. |
| ClinicalTrials.gov Identifier: | NCT02008526 |
| Other Study ID Numbers: |
R01DA035092 ( U.S. NIH Grant/Contract ) |
| First Posted: | December 11, 2013 Key Record Dates |
| Results First Posted: | September 18, 2017 |
| Last Update Posted: | September 18, 2017 |
| Last Verified: | June 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Text Messaging mHealth Methamphetamine HIV AIDS |

